With share price trading at about $0.4, the price level before MEG contract,
I believe the market or more specifically a few shareholders think MEG contract is not worth much or the recent decline in US sales is permanent and a sign of weakening competitive advantages of its products.
To me, the US sale is probably delayed to 2018 and the potential value of MEG and Somfit will continue to unfold, during the next few years.
For illiquid stocks like CMP, it is so easy to see the herd effect that "people are buying at record high and selling at record lows"
To me, CMP value continues to grow, despite of short-term under performance.
Hopefully, preliminary report will be released soon, to provide forward looking indication of CMP's future.
CMP Price at posting:
41.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)